ACG Continues Production Amid COVID-19 pandemic

▴ ACG Continues Production Amid COVID-19 Pabdemic
ACG Continues Production to Meet Mission-critical Pharmaceutical Requirements in Tackling COVID-19, With Employee Safety a Top Priority Across its Operations

Despite widespread disruption, ACG is continuing production in its factories across the world, and helping to keep supply chains running smoothly to meet mission-critical demands. Being a crucial supplier to the pharmaceutical industry, in these difficult times comes with a huge duty of care to employees and associates, and ACG continues to do 'everything and more' to protect their safety and wellbeing.

ACG provides dosage capsules and high-barrier blister packaging films for all specifications, plus advanced machinery and technical support for pharmaceutical facilities. All ACG Capsule and ACG Films & Foils factories across the globe are currently running at full capacity, and all orders are being fulfilled.

Of course, employee safety remains a primary concern for ACG at this time, and strict and comprehensive COVID-19 precautionary measures are in place at ACG factories across India, Europe and Brazil to ensure the continued health and safety of all ACG associates.

At plant level, measures comprise daily sanitising of factory premises and property, including common areas, offices and vehicles - plus strict social distancing rules, employee screening, sanitiser dispensers throughout factories, awareness sessions from medical professionals, and full access to personal protective equipment (PPE). Such steps are reviewed and updated continuously to align with expert health advice and policy.

To encourage higher hygiene and safety standards, ACG factory shifts are currently 12 hours, to support social distancing measures and reduce travel between factories and communities. ACG has also arranged medically-equipped isolation facilities, and provides worker accommodation at selected sites.

In 'lockdown' countries, ACG continues to provide workers with ready-packed vegetables, groceries and sanitation kits to take home to their families. Meanwhile, ACG has arranged special vehicles for safer commuting between home and work, which are sanitised before and after every journey. In India, ACG has also given an additional insurance cover of INR 200,000 (over and above the existing policies), insuring all its employees and their families against medical expenses that may occur this year.

Every ACG plant worldwide has a contingency plan and Standard Operating Procedure for suspected or confirmed cases, and for quarantine.

Additional measures for product transportation

To ensure ACG products and equipment reach customers on time, ACG has been working closely with local government officials to keep manufacturing supply chains as open and efficient as possible. This includes sourcing, securing and distributing everything from gelatin to food colouring and additives, to packaging materials, and more.

ACG Capsules and ACG Films & Foils are classified as 'Essentials' by government authorities, so delivery vehicles owned by ACG and its suppliers are ensured safe and smooth transit between key supply-chain locations.

On taking extraordinary safety measures for the ACG workforce, Mr. Sunil Jha, Group CHRO, said, "People are our first concern - our associates, suppliers, partners, customers, and end-users. All efforts at ACG are dedicated to helping make people, and the world, healthier. It may be our business, but right now it's also about so much more. We salute the spirit of our employees who are coming to work every day and doing their bit in fighting the COVID-19 virus. ACG stands with them."

Tags : #Acg #Coronavirus #Additionalmeasures #Continuesproduction #Supplychain

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Smart Operating Rooms: The Future of Hospital OTNovember 21, 2026
Smartphone Diagnostics: Phones as Medical Screening ToolsNovember 21, 2026
AI-Enabled Endoscopy: Can It Detect More Than the Human Eye?November 20, 2026
AI-Enabled Endoscopy: Can It Detect More Than the Human Eye?November 20, 2026
Hospital-at-Home in India: Can Technology Deliver Safe Care?November 20, 2026
Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026